Health products can be an extraordinary way to treat and cure serious diseases.
Yet even the most successful ones have one crucial flaw: they can’t be made from standard pharmaceutical ingredients.
A new study, published in the journal Nature, finds that, in the case of cancer drugs, there’s an extra piece of the puzzle: the delivery mechanism.
The scientists, from the University of Zurich and the University at Buffalo, found that the drug can be delivered using nanoparticles, rather than using a standard chemical.
The nanoparticles’ structure is not exactly that of a single molecule, but instead the same one as a nanoparticle that has been coated with a drug’s active ingredient.
The researchers say this allows the drug to be more effective than a standard, or non-standard, route of delivery.
The researchers found that a standard pharmaceutical formulation, such as a drug that has already been given to humans, is not able to deliver the drug as effectively as a non-supplementary drug.
The discovery could provide a new way to deliver drugs.
A drug that is delivered through nanoparticles could be much safer than a drug delivered through a standard route, according to the researchers.
The drug-pushing process of drug delivery could have huge benefits for the future of cancer treatments, and it could also provide a cheap, low-cost way to find drugs, they say.
“We believe that nanoparticle delivery of cancer-drugs could become a viable and affordable alternative to traditional pharmaceutical delivery, with the potential to deliver therapeutics at lower cost,” they say in their study.
This isn’t the first time researchers have looked at how nanoparticles work.
In 2011, researchers found the same trick could work to deliver nanoparticles to cancer cells, and they also made a nanoparticles delivery system that could deliver drugs to the body.
The technology was named Powjet, and the company has since been acquired by Tekmat.
However, the researchers say the nanoparticles themselves can’t deliver drugs through them, and that it is still unclear whether they work in a way similar to traditional nanoparticles.
More: “Our research shows that nanoparticles are capable of delivering drugs through a nonstandard route, but we need more studies to confirm this,” says co-author Christian C. Stobert from the Department of Molecular Biophysics at the University’s Zürich campus.